PDF) The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
Nonalcoholic Fatty Liver Disease: Diagnosis and Management | AAFP
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise | Nature Reviews Gastroenterology & Hepatology
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications - ScienceDirect
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. - Abstract - Europe PMC
PDF) How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index)?
BioPredictive · FibroMax
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
BioPredictive · FibroTest-ActiTest
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
Fibromax
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine
Biomedicines | Free Full-Text | Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data | PLOS ONE
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers - ScienceDirect
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Clinical case: NAFLD
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
